|Bid||177.20 x 1000|
|Ask||177.50 x 900|
|Day's Range||177.10 - 185.09|
|52 Week Range||115.03 - 321.30|
|Beta (5Y Monthly)||1.73|
|PE Ratio (TTM)||6.19|
|Earnings Date||Feb 22, 2023 - Feb 27, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||209.47|
Cloud computing is not a new frontier in health care, but it is finally starting to bear some fruit, AWS exec Dr. Taha Kass-Hout, told Yahoo Finance.
The U.S. Centers for Disease Control and Prevention (CDC) on Friday expanded the use of COVID-19 vaccines that target both the original coronavirus and Omicron sub-variants to include children aged 6 months through 5 years. The development comes a day after the U.S. Food and Drug Administration authorized the updated shots from Moderna as well as Pfizer and its partner BioNTech for use in children as young as 6 months. Children aged 6 months through 5 years will now be eligible to get a Moderna bivalent booster 2 months after their final primary vaccination dose for COVID-19.
Amid a rise in seasonal respiratory illnesses in younger children across the country, the FDA broadens the label of authorized bivalent Omicron BA.4/BA.5-adapted vaccines to include children as young as six months.